Document is current
Any future updates will be listed below
-
Authors
Nefzger, Christian M. https://orcid.org/0000-0003-4631-5633
Jardé, Thierry
Srivastava, Akanksha
Schroeder, Jan https://orcid.org/0000-0001-5270-0605
Rossello, Fernando J.
Horvay, Katja
Prasko, Mirsada
Paynter, Jacob M.
Chen, Joseph
Weng, Chen-Fang
Sun, Yu B. Y.
Liu, Xiaodong
Chan, Eva https://orcid.org/0000-0003-3996-4491
Deshpande, Nikita
Chen, Xiaoli
Li, Y. Jinhua
Pflueger, Jahnvi
Engel, Rebekah M.
Knaupp, Anja S.
Tsyganov, Kirill
Nilsson, Susan K. https://orcid.org/0000-0002-7926-7335
Lister, Ryan
Rackham, Owen J. L.
Abud, Helen E. https://orcid.org/0000-0003-3792-4023
Polo, Jose M. https://orcid.org/0000-0002-2531-778X
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1061883)
Department of Health | National Health and Medical Research Council (APP1146623)
Department of Health | National Health and Medical Research Council (APP1129600)
Department of Health | National Health and Medical Research Council (APP1061883)
Department of Health | National Health and Medical Research Council (APP1100531)
Sylvia and Charles Senior Medical Viertel Fellowship
- License Information
-
More Information
Article History
Received: 7 May 2021
Accepted: 25 April 2022
First Online: 16 June 2022
Competing interests
: O.J.L.R. and J.M. Polo. are co-founders of Mogrify Ltd., a cell therapy company. The rest of the authors declare that there are no competing interests.
